1. Home
  2. VMO vs EMBC Comparison

VMO vs EMBC Comparison

Compare VMO & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Invesco Municipal Opportunity Trust

VMO

Invesco Municipal Opportunity Trust

HOLD

Current Price

$9.78

Market Cap

658.2M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$12.84

Market Cap

719.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VMO
EMBC
Founded
1992
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
658.2M
719.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VMO
EMBC
Price
$9.78
$12.84
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
254.7K
596.9K
Earning Date
01-01-0001
02-05-2026
Dividend Yield
4.39%
4.74%
EPS Growth
N/A
20.90
EPS
N/A
1.62
Revenue
N/A
$1,080,400,000.00
Revenue This Year
N/A
$2.18
Revenue Next Year
N/A
$0.09
P/E Ratio
N/A
$7.81
Revenue Growth
N/A
N/A
52 Week Low
$7.86
$9.20
52 Week High
$9.87
$20.63

Technical Indicators

Market Signals
Indicator
VMO
EMBC
Relative Strength Index (RSI) 67.21 57.84
Support Level $9.70 $12.51
Resistance Level $9.78 $13.03
Average True Range (ATR) 0.06 0.42
MACD 0.02 0.15
Stochastic Oscillator 87.93 84.85

Price Performance

Historical Comparison
VMO
EMBC

About VMO Invesco Municipal Opportunity Trust

Invesco Municipal Opportunity Trust is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: